2026 NPPES data Oral and Maxillofacial Surgery (Dentist) NPI 1316226087 MD, DDS
Verify on CMS →

MATTHEW RADANT, MD, DDS

Oral and Maxillofacial Surgery (Dentist) in TULSA, Oklahoma. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
385
Medicare Part D claims · 80 beneficiaries · Oral and Maxillofacial Surgery (Dentist) avg: 378
Industry payments
$705.4
8 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MATTHEW RADANT, MD, DDS filed 385 Medicare Part D claims in 2023 as a Oral and Maxillofacial Surgery (Dentist) in TULSA, Oklahoma.

385
Part D claims, 2023
$705.4
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MATTHEW RADANT, MD, DDS's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

385 Top 43% higher than 57% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about MATTHEW RADANT, MD, DDS?

Quality data not reported

NPI registry status

Active

Issued 08/11/2011

NPI 1316226087

Primary specialty

Oral and Maxillofacial Surgery (Dentist)

Mid-sized

7,631 US NPIs in this specialty

Medicare Part D claims

385 2% vs specialty avg

2023 prescription claims

Specialty avg: 378

Specialty distribution in Oklahoma

How Oral and Maxillofacial Surgery (Dentist) compares to other specialties among Oklahoma providers

Oklahoma providers

Oral and Maxillofacial Surgery (Dentist) share within Oklahoma

1. Oral and Maxillofacial Surgery (Dentist)42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oral and Maxillofacial Surgery (Dentist) share within Oklahoma

Specialty board-certification context

Estimated specialty board-certified rate — Oral and Maxillofacial Surgery (Dentist) (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oral and Maxillofacial Surgery (Dentist) ABMS/AOA estimate

Est. board-certified rate (Oral and Maxillofacial Surgery (Dentist)) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oral and Maxillofacial Surgery (Dentist)) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MATTHEW RADANT, MD, DDS appears in the CMS NPPES registry as a Oral and Maxillofacial Surgery (Dentist) provider holding MD, DDS credentials at 6161 S YALE AVE, TULSA, OK, 74136, with a listed phone of (918) 494-1805. NPI 1316226087 was issued on 08/11/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RADANT most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 385 prescription claims written by this provider, covering 80 Medicare beneficiaries and totaling roughly $7K in drug spend, with an opioid prescribing rate of 12.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oral and Maxillofacial Surgery (Dentist) is a mid-sized specialty nationwide, with 7,631 enrolled providers across 52 states and an average of 378 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

6161 S YALE AVE
TULSA, OK 74136

Provider Details

NPI 1316226087
Specialty Oral and Maxillofacial Surgery (Dentist)
Credentials MD, DDS
Gender Male
NPI Issued 08/11/2011

Hospital and facility affiliations

Facilities where MATTHEW RADANT, MD, DDS bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CARE COMMUNICATIONS LLC
TULSA, OK
WARREN CLINIC INC
TULSA, OK

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MATTHEW RADANT, MD, DDS. Source: openpaymentsdata.cms.gov.

Total received

$705

Largest payer

KLS-Martin L.P.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

385
Total Claims
$7K
Total Drug Cost
80
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
397
Total Day Supply
5,427
Generic Drug Cost
$4K
Opioid Claims
49 (12.7% rate)
Antibiotic Claims
103

Patient Demographics

Average Patient Age
71.4 years
Avg HCC Risk Score
1.68
Gender Split
54% female / 46% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MATTHEW RADANT, MD, DDS prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Chlorhexidine Gluconate
141
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
57
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
24
Nystatin
21
Lidocaine Hcl Viscous
Lidocaine Hcl
19
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
17
Fluconazole
11
Levofloxacin
11
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oral and Maxillofacial Surgery (Dentist) Overview

How MATTHEW RADANT, MD, DDS fits within the Oral and Maxillofacial Surgery (Dentist) landscape nationally.

7,631
Oral and Maxillofacial Surgery (Dentist) Providers in US
52
States with Oral and Maxillofacial Surgery (Dentist)
378
Avg Claims per Provider

MATTHEW RADANT, MD, DDS's 385 claims are above the specialty average of 378.

Nearby Oral and Maxillofacial Surgery (Dentist) Providers in Oklahoma

Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as RADANT.

Compare Oral and Maxillofacial Surgery (Dentist) nationally: see state-by-state distribution →

Frequently Asked Questions

What is MATTHEW RADANT, MD, DDS's specialty?
MATTHEW RADANT, MD, DDS specializes in Oral and Maxillofacial Surgery (Dentist) and practices in TULSA, Oklahoma. Credentials: MD, DDS.
How much does MATTHEW RADANT, MD, DDS prescribe under Medicare Part D?
In 2023, MATTHEW RADANT, MD, DDS wrote 385 Medicare Part D claims totaling $7K in drug costs for 80 beneficiaries.
Where is MATTHEW RADANT, MD, DDS located?
MATTHEW RADANT, MD, DDS is located at 6161 S YALE AVE, TULSA, OK, 74136. Phone: (918) 494-1805.
What is MATTHEW RADANT, MD, DDS's NPI number?
MATTHEW RADANT, MD, DDS's National Provider Identifier (NPI) is 1316226087, issued on 08/11/2011.
Does MATTHEW RADANT, MD, DDS prescribe opioids?
Yes, MATTHEW RADANT, MD, DDS had 49 opioid claims in 2023 with an opioid prescribing rate of 12.7%.
How many Oral and Maxillofacial Surgery (Dentist) providers are there in the US?
There are 7,631 Oral and Maxillofacial Surgery (Dentist) providers across 52 states in the US. The average Oral and Maxillofacial Surgery (Dentist) provider writes 378 Medicare Part D claims per year.
What drugs does MATTHEW RADANT, MD, DDS prescribe most often?
Based on 2023 Medicare Part D data, MATTHEW RADANT, MD, DDS's most frequently prescribed drugs include Chlorhexidine Gluconate, Amoxicillin-Clavulanate Potass, Oxycodone-Acetaminophen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MATTHEW RADANT, MD, DDS accept Medicare?
MATTHEW RADANT, MD, DDS appears in CMS Medicare data with 385 Part D claims and 80 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MATTHEW RADANT, MD, DDS's credentials?
MATTHEW RADANT, MD, DDS's NPI is 1316226087 with credentials MD, DDS. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology